Matthew Jordan

University of Cambridge - Faculty of Law

10 West Road

Cambridge, CB3 9DZ

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

86

SSRN CITATIONS

2

CROSSREF CITATIONS

1

Scholarly Papers (3)

1.

After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?

35 Nature Biotechnology 820-825
Number of pages: 31 Posted: 22 May 2018
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 39 (478,899)
Citation 1

Abstract:

Loading...

Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research

2.

Was the Myriad Decision a ‘Surgical Strike’ on Isolated DNA Patents, or Does it Have Wider Impacts?

36(12) Nature Biotechnology 1146
Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 18 Sep 2019
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 27 (539,214)
Citation 1

Abstract:

Loading...

patents, gene patents, Myriad, wider impacts, DNA, markedly different, naturally occurring compounds, empirical, Biotechnology, US

3.

IP Policies for Large Bioresources: The Fiction, Fantasy and Future of Openness

Global Genes, Local Concerns (2019), University of Cambridge Faculty of Law Research Paper No. 2/2020
Number of pages: 20 Posted: 10 Jun 2019 Last Revised: 21 May 2020
Kathleen Liddell, John Liddicoat and Matthew Jordan
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 20 (583,146)

Abstract:

Loading...

openness, open innovation, open science, genomics, synthetic biology